{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:16:51Z","timestamp":1790720211686,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03928-w","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:02:31Z","timestamp":1748523751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Explore the effect of HIF-PHI on blood pressure variation rate and anemia efficacy in maintenance hemodialysis patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu-ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-hui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-tian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"4","key":"3928_CR1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/gfn117","volume":"23","author":"J Coresh","year":"2008","unstructured":"Coresh J, Stevens LA, Levey AS. Chronic kidney disease is common: what do we do next?[J]. Nephrol Dial Transpl. 2008;23(4):1122\u20135.","journal-title":"Nephrol Dial Transpl"},{"key":"3928_CR2","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhao MH, Zuo L et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report[J]. Kidney Int Suppl (2011), 2020,10(2):e97-e185.","DOI":"10.1016\/j.kisu.2020.09.001"},{"issue":"5S1","key":"3928_CR3","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1053\/j.ajkd.2016.05.021","volume":"68","author":"JA Morfin","year":"2016","unstructured":"Morfin JA, Fluck RJ, Weinhandl ED, et al. Intensive hemodialysis and treatment complications and Tolerability[J]. Am J Kidney Dis. 2016;68(5S1):S43\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"9818","key":"3928_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"5","key":"3928_CR5","first-page":"562","volume":"4","author":"D Lin Pan","year":"2009","unstructured":"Lin Pan D, Xiaoqiang Y, Min, et al. Anemia in patients with chronic kidney disease illness survey [J]. Fudan Univ J Med Sci. 2009;4(5):562\u20135.","journal-title":"Fudan Univ J Med Sci"},{"issue":"4","key":"3928_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2014.114","volume":"86","author":"T Kuragano","year":"2014","unstructured":"Kuragano T, Matsumura O, Matsuda A, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients[J]. Kidney Int. 2014;86(4):845\u201354.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"3928_CR7","first-page":"S110","volume":"21","author":"VH Haase","year":"2017","unstructured":"Haase VH. HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism[J]. Hemodial Int. 2017;21(Suppl 1):S110\u201324.","journal-title":"Hemodial Int"},{"issue":"3","key":"3928_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1681\/ASN.2019020213","volume":"31","author":"EK Batchelor","year":"2020","unstructured":"Batchelor EK, Kapitsinou P, Pergola PE, et al. Iron Deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and Treatment[J]. J Am Soc Nephrol. 2020;31(3):456\u201368.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3928_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.kint.2017.02.035","volume":"92","author":"M Sugahara","year":"2017","unstructured":"Sugahara M, Tanaka T, Nangaku M. Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease[J]. Kidney Int. 2017;92(2):306\u201312.","journal-title":"Kidney Int"},{"issue":"5","key":"3928_CR10","first-page":"452","volume":"20","author":"W Wang Yang","year":"2019","unstructured":"Wang Yang W, Ribao. Chronic kidney disease (CKD) is the basis and clinical studies of renal anemia status and progress [J]. Chin J Integr Traditional Western Nephrol. 2019;20(5):452\u20135.","journal-title":"Chin J Integr Traditional Western Nephrol"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2369-14-2","volume":"14","author":"J Portoles","year":"2013","unstructured":"Portoles J, Gorriz JL, Rubio E, et al. The development of anemia is associated to poor prognosis in NKF\/KDOQI stage 3 chronic kidney disease[J]. BMC Nephrol. 2013;14:2.","journal-title":"BMC Nephrol"},{"issue":"2","key":"3928_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10157-017-1468-8","volume":"22","author":"Y Sato","year":"2018","unstructured":"Sato Y, Fujimoto S, Konta T, et al. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease[J]. Clin Exp Nephrol. 2018;22(2):388\u201394.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"3928_CR13","first-page":"60","volume":"4","author":"M Anees","year":"2010","unstructured":"Anees M, Mumtaz A, Ibrahim M, et al. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis[J]. Iran J Kidney Dis. 2010;4(1):60\u20135.","journal-title":"Iran J Kidney Dis"},{"key":"3928_CR14","doi-asserted-by":"crossref","unstructured":"Kawahara K, Minakuchi J, Yokota N et al. Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis[J]. Nephrol (Carlton), 2015,20 Suppl 4:29\u201332.","DOI":"10.1111\/nep.12647"},{"issue":"9","key":"3928_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cardfail.2009.05.010","volume":"15","author":"J Comin-Colet","year":"2009","unstructured":"Comin-Colet J, Ruiz S, Cladellas M, et al. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes[J]. J Card Fail. 2009;15(9):727\u201335.","journal-title":"J Card Fail"},{"issue":"24","key":"3928_CR16","doi-asserted-by":"publisher","first-page":"e3872","DOI":"10.1097\/MD.0000000000003872","volume":"95","author":"Y Li","year":"2016","unstructured":"Li Y, Shi H, Wang WM, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study[J]. Med (Baltim). 2016;95(24):e3872.","journal-title":"Med (Baltim)"},{"issue":"6","key":"3928_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000351175","volume":"37","author":"PA McCullough","year":"2013","unstructured":"McCullough PA, Barnhart HX, Inrig JK, et al. Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease[J]. Am J Nephrol. 2013;37(6):549\u201358.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3928_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ki.2014.275","volume":"87","author":"GR Bailie","year":"2015","unstructured":"Bailie GR, Larkina M, Goodkin DA, et al. Data from the Dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality[J]. Kidney Int. 2015;87(1):162\u20138.","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"3928_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ndt\/10.supp2.74","volume":"10","author":"G Maschio","year":"1995","unstructured":"Maschio G. Erythropoietin and systemic hypertension[J]. Nephrol Dial Transpl. 1995;10(Suppl 2):74\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"3928_CR20","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1007\/s12325-021-01904-6","volume":"38","author":"B Csiky","year":"2021","unstructured":"Csiky B, Schomig M, Esposito C, et al. Roxadustat for the Maintenance Treatment of Anemia in patients with end-stage kidney disease on stable Dialysis: a European phase 3, randomized, Open-Label, active-controlled study (PYRENEES)[J]. Adv Ther. 2021;38(10):5361\u201380.","journal-title":"Adv Ther"},{"issue":"4","key":"3928_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2020111638","volume":"33","author":"S Fishbane","year":"2022","unstructured":"Fishbane S, Pollock CA, El-Shahawy M, et al. Roxadustat Versus Epoetin Alfa for Treating Anemia in patients with chronic kidney disease on Dialysis: results from the Randomized Phase 3 ROCKIES Study[J]. J Am Soc Nephrol. 2022;33(4):850\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3928_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00041552-200305000-00011","volume":"12","author":"TE Strandberg","year":"2003","unstructured":"Strandberg TE, Pitkala K. What is the most important component of blood pressure: systolic, diastolic or pulse pressure?[J]. Curr Opin Nephrol Hypertens. 2003;12(3):293\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"3928_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5301\/jn.5000202","volume":"26","author":"VL Del","year":"2013","unstructured":"Del VL, Lusenti T, Del RG, et al. Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study[J]. J Nephrol. 2013;26(4):745\u201354.","journal-title":"J Nephrol"},{"issue":"4","key":"3928_CR24","doi-asserted-by":"publisher","first-page":"e266243","DOI":"10.1371\/journal.pone.0266243","volume":"17","author":"B Abdelazeem","year":"2022","unstructured":"Abdelazeem B, Shehata J, Abbas KS, et al. The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis dependent chronic kidney disease patients: an updated systematic review and meta-analysis of randomized clinical trials[J]. PLoS ONE. 2022;17(4):e266243.","journal-title":"PLoS ONE"},{"issue":"3","key":"3928_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.111.00160","volume":"62","author":"Y Huang","year":"2013","unstructured":"Huang Y, Di Lorenzo A, Jiang W, et al. Hypoxia-inducible factor-1alpha in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-gamma-angiotensin II receptor type 1 axis[J]. Hypertension. 2013;62(3):634\u201340.","journal-title":"Hypertension"},{"issue":"3","key":"3928_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.kint.2016.05.020","volume":"90","author":"S Mokas","year":"2016","unstructured":"Mokas S, Lariviere R, Lamalice L, et al. Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification[J]. Kidney Int. 2016;90(3):598\u2013609.","journal-title":"Kidney Int"},{"issue":"2","key":"3928_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cardiores.2005.01.012","volume":"66","author":"HH Dao","year":"2005","unstructured":"Dao HH, Essalihi R, Bouvet C, et al. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension[J]. Cardiovasc Res. 2005;66(2):307\u201317.","journal-title":"Cardiovasc Res"},{"key":"3928_CR28","doi-asserted-by":"crossref","unstructured":"Yu J, Wang S, Shi W et al. Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS[J]. JCI Insight, 2021,6(18).","DOI":"10.1172\/jci.insight.133690"},{"issue":"3","key":"3928_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/HYPERTENSIONAHA.114.04639","volume":"65","author":"M Satoh","year":"2015","unstructured":"Satoh M, Ohkubo T, Asayama K, et al. Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for Cardiovascular Prevention from Observational cohorts in Japan[J]. Hypertension. 2015;65(3):517\u201324.","journal-title":"Hypertension"},{"issue":"6","key":"3928_CR30","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.187252","volume":"59","author":"H Arima","year":"2012","unstructured":"Arima H, Murakami Y, Lam TH, et al. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region[J]. Hypertension. 2012;59(6):1118\u201323.","journal-title":"Hypertension"},{"issue":"11","key":"3928_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/jhh.2013.22","volume":"27","author":"NC Barengo","year":"2013","unstructured":"Barengo NC, Antikainen R, Kastarinen M, et al. The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort[J]. J Hum Hypertens. 2013;27(11):693\u20137.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"3928_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/01.HYP.32.1.52","volume":"32","author":"S Omboni","year":"1998","unstructured":"Omboni S, Parati G, Castiglioni P, et al. Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure[J]. Hypertension. 1998;32(1):52\u20138.","journal-title":"Hypertension"},{"issue":"2","key":"3928_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.111.178657","volume":"59","author":"JK Johansson","year":"2012","unstructured":"Johansson JK, Niiranen TJ, Puukka PJ, et al. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study[J]. Hypertension. 2012;59(2):212\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"3928_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/STROKEAHA.117.019107","volume":"49","author":"A Webb","year":"2018","unstructured":"Webb A, Mazzucco S, Li L, et al. Prognostic significance of blood pressure variability on beat-to-beat monitoring after transient ischemic attack and Stroke[J]. Stroke. 2018;49(1):62\u20137.","journal-title":"Stroke"},{"issue":"7","key":"3928_CR35","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.2215\/CJN.11331210","volume":"6","author":"JJ Carrero","year":"2011","unstructured":"Carrero JJ, de Jager DJ, Verduijn M, et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis[J]. Clin J Am Soc Nephrol. 2011;6(7):1722\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3928_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ajh\/hpv102","volume":"29","author":"D Jiang","year":"2016","unstructured":"Jiang D, Tokashiki M, Hayashi H, et al. Augmented blood pressure variability in Hypertension Induced by Angiotensin II in Rats[J]. Am J Hypertens. 2016;29(2):163\u20139.","journal-title":"Am J Hypertens"},{"issue":"3","key":"3928_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.ajkd.2011.11.026","volume":"59","author":"JE Flythe","year":"2012","unstructured":"Flythe JE, Kunaparaju S, Dinesh K, et al. Factors associated with intradialytic systolic blood pressure variability[J]. Am J Kidney Dis. 2012;59(3):409\u201318.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"3928_CR38","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/HJH.0000000000000969","volume":"34","author":"GS Stergiou","year":"2016","unstructured":"Stergiou GS, Parati G, Vlachopoulos C, et al. Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability[J]. J Hypertens. 2016;34(9):1665\u201377.","journal-title":"J Hypertens"},{"issue":"2","key":"3928_CR39","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYPERTENSIONAHA.110.155325","volume":"56","author":"SD Pierdomenico","year":"2010","unstructured":"Pierdomenico SD. Indices of blood pressure variability and cardiovascular risk[J]. Hypertension. 2010;56(2):e21. author reply e22.","journal-title":"Hypertension"},{"issue":"3","key":"3928_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/01.hjh.0000160205.81652.5a","volume":"23","author":"L Mena","year":"2005","unstructured":"Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability[J]. J Hypertens. 2005;23(3):505\u201311.","journal-title":"J Hypertens"},{"issue":"9","key":"3928_CR41","first-page":"633","volume":"21","author":"Yu-chao Zhao","year":"2012","unstructured":"Zhao Yu-chao, Hui-ping ZHAO, Bei WU, et al. Effect of roxadustat on blood pressure in maintenance peritoneal dialysis patients [J]. Chin J Blood Purif. 2012;21(9):633\u20137.","journal-title":"Chin J Blood Purif"},{"issue":"4","key":"3928_CR42","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/01.HYP.0000239206.64270.5f","volume":"48","author":"CM McEniery","year":"2006","unstructured":"McEniery CM, Wallace S, Mackenzie IS, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans[J]. Hypertension. 2006;48(4):602\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"3928_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1681\/ASN.2018101007","volume":"30","author":"Y Sakaguchi","year":"2019","unstructured":"Sakaguchi Y, Hamano T, Wada A, et al. Types of erythropoietin-stimulating agents and mortality among patients undergoing Hemodialysis[J]. J Am Soc Nephrol. 2019;30(6):1037\u201348.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3928_CR44","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1182\/blood-2009-07-230870","volume":"115","author":"ML Janmaat","year":"2010","unstructured":"Janmaat ML, Heerkens JL, de Bruin AM, et al. Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release[J]. Blood. 2010;115(7):1453\u201360.","journal-title":"Blood"},{"issue":"6","key":"3928_CR45","first-page":"825","volume":"26","author":"B Xianglan","year":"2006","unstructured":"Xianglan B, Ying B. Clinical observation of hypertension induced by recombinant human erythropoietin [J]. Chin J Gerontol. 2006;26(6):825\u20136.","journal-title":"Chin J Gerontol"},{"issue":"4","key":"3928_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0272-6386(99)70223-4","volume":"33","author":"G Johannsson","year":"1999","unstructured":"Johannsson G, Bengtsson BA, Ahlmen J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement[J]. Am J Kidney Dis. 1999;33(4):709\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"3928_CR47","doi-asserted-by":"publisher","first-page":"e111838","DOI":"10.1371\/journal.pone.0111838","volume":"9","author":"I Flamme","year":"2014","unstructured":"Flamme I, Oehme F, Ellinghaus P, et al. Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects[J]. PLoS ONE. 2014;9(11):e111838.","journal-title":"PLoS ONE"},{"issue":"40","key":"3928_CR48","first-page":"3213","volume":"96","author":"ZK Yu","year":"2016","unstructured":"Yu ZK, Han YJ, Chen DD, et al. [Association between genetic polymorphisms of HIF-2alpha gene and high altitude pulmonary hypertension in Han population][J]. Zhonghua Yi Xue Za Zhi. 2016;96(40):3213\u20137.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"22","key":"3928_CR49","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1074\/jbc.M117.788562","volume":"292","author":"S Hwang","year":"2017","unstructured":"Hwang S, Nguyen AD, Jo Y, et al. Hypoxia-inducible factor 1alpha activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver[J]. J Biol Chem. 2017;292(22):9382\u201393.","journal-title":"J Biol Chem"},{"issue":"11","key":"3928_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","volume":"381","author":"N Chen","year":"2019","unstructured":"Chen N, Hao C, Liu BC, et al. Roxadustat Treatment for Anemia in patients undergoing long-term Dialysis[J]. N Engl J Med. 2019;381(11):1011\u201322.","journal-title":"N Engl J Med"},{"issue":"4","key":"3928_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","volume":"115","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States[J]. Am J Med. 2003;115(4):291\u20137.","journal-title":"Am J Med"},{"issue":"8","key":"3928_CR52","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jamainternmed.2016.3819","volume":"176","author":"D Zhou","year":"2016","unstructured":"Zhou D, Wang S, Tian T. Uncontrolled hypertension and risk of Cardiovascular Mortality in China[J]. JAMA Intern Med. 2016;176(8):1233\u20134.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"3928_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2016.0190","volume":"176","author":"S Lewington","year":"2016","unstructured":"Lewington S, Lacey B, Clarke R, et al. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China[J]. JAMA Intern Med. 2016;176(4):524\u201332.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"3928_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1081\/CEH-100102661","volume":"23","author":"HC Deter","year":"2001","unstructured":"Deter HC, Buchholz K, Schorr U, et al. Salt-sensitivity and other predictors of stress-related cardiovascular reactivity in healthy young males[J]. Clin Exp Hypertens. 2001;23(3):213\u201325.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"3928_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00774-017-0898-4","volume":"37","author":"K Yoneki","year":"2019","unstructured":"Yoneki K, Kitagawa J, Hoshi K, et al. Association between frailty and bone loss in patients undergoing maintenance hemodialysis[J]. J Bone Min Metab. 2019;37(1):81\u20139.","journal-title":"J Bone Min Metab"},{"key":"3928_CR56","doi-asserted-by":"publisher","first-page":"1071342","DOI":"10.3389\/fmed.2023.1071342","volume":"10","author":"K Hirai","year":"2023","unstructured":"Hirai K, Kaneko S, Minato S, et al. Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease[J]. Front Med (Lausanne). 2023;10:1071342.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"3928_CR57","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2010.11.003","volume":"214","author":"JL Abramson","year":"2011","unstructured":"Abramson JL, Lewis C, Murrah NV. Body mass index, leptin, and ambulatory blood pressure variability in healthy adults[J]. Atherosclerosis. 2011;214(2):456\u201361.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3928_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ndt\/gfx037","volume":"33","author":"JA Chou","year":"2018","unstructured":"Chou JA, Streja E, Nguyen DV, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients[J]. Nephrol Dial Transpl. 2018;33(1):149\u201359.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"3928_CR59","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/ejhf.1835","volume":"22","author":"J Cautela","year":"2020","unstructured":"Cautela J, Tartiere JM, Cohen-Solal A, Bellemain-Appaix A, Theron A, Tibi T, Januzzi JL Jr, Roubille F, Girerd N. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. Eur J Heart Fail. 2020;22(8):1357\u201365.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"3928_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/ki.2013.237","volume":"84","author":"J Park","year":"2013","unstructured":"Park J, Rhee CM, Sim JJ, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival[J]. Kidney Int. 2013;84(4):795\u2013802.","journal-title":"Kidney Int"},{"issue":"2","key":"3928_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00774-014-0582-x","volume":"33","author":"N Sasaki","year":"2015","unstructured":"Sasaki N, Tsunoda M, Ikee R, et al. Efficacy and safety of eldecalcitol, a new active vitamin D3 analog, in the bone metabolism of postmenopausal women receiving maintenance hemodialysis[J]. J Bone Min Metab. 2015;33(2):213\u201320.","journal-title":"J Bone Min Metab"},{"issue":"6","key":"3928_CR62","first-page":"456","volume":"11","author":"A Nazarian","year":"2017","unstructured":"Nazarian A, Hasankhani M, Aghajany-Nasab M, et al. Association between Klotho Gene polymorphism and markers of bone metabolism in patients receiving maintenance hemodialysis in Iran[J]. Iran J Kidney Dis. 2017;11(6):456\u201360.","journal-title":"Iran J Kidney Dis"},{"issue":"12","key":"3928_CR63","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1681\/ASN.2010010116","volume":"21","author":"WM Bernhardt","year":"2010","unstructured":"Bernhardt WM, Wiesener MS, Scigalla P, et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD[J]. J Am Soc Nephrol. 2010;21(12):2151\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3928_CR64","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/ndt\/gfab349","volume":"37","author":"J Barratt","year":"2022","unstructured":"Barratt J, Andric B, Tataradze A, et al. Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a phase 3, randomised, open-label, active-controlled study (DOLOMITES)[J]. Nephrol Dial Transpl. 2022;37(4):805.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"3928_CR65","doi-asserted-by":"publisher","first-page":"e252439","DOI":"10.1371\/journal.pone.0252439","volume":"16","author":"C Ogawa","year":"2021","unstructured":"Ogawa C, Tsuchiya K, Tomosugi N, et al. Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa[J]. PLoS ONE. 2021;16(6):e252439.","journal-title":"PLoS ONE"},{"issue":"2","key":"3928_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000504850","volume":"6","author":"ZL Li","year":"2020","unstructured":"Li ZL, Tu Y, Liu BC. Treatment of renal Anemia with Roxadustat: advantages and Achievement[J]. Kidney Dis (Basel). 2020;6(2):65\u201373.","journal-title":"Kidney Dis (Basel)"},{"issue":"9","key":"3928_CR67","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin[J]. N Engl J Med. 1998;339(9):584\u201390.","journal-title":"N Engl J Med"},{"issue":"20","key":"3928_CR68","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease[J]. N Engl J Med. 2006;355(20):2085\u201398.","journal-title":"N Engl J Med"},{"key":"3928_CR69","unstructured":"Zhen yu, yong-mei liu. Correlation between intradialytic blood pressure variability and chronic kidney disease-mineral and bone abnormalities in maintenance hemodialysis patients [J]. J Bengbu Med Univ, 2017 (12): 1652\u20133."},{"issue":"10","key":"3928_CR70","doi-asserted-by":"publisher","first-page":"300060523120447","DOI":"10.1177\/03000605231204475","volume":"51","author":"J Song","year":"2023","unstructured":"Song J, Chen X, Zhou L, Yu W, Liu H, Yuan F. Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients. J Int Med Res. 2023;51(10):3000605231204475.","journal-title":"J Int Med Res"},{"key":"3928_CR71","doi-asserted-by":"crossref","unstructured":"Denny GB, Deger SM, Chen G et al. Leucine disposal rate for assessment of amino acid metabolism in maintenance hemodialysis patients[J]. BMC Nutr, 2016,2.","DOI":"10.1186\/s40795-016-0071-9"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03928-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:06:49Z","timestamp":1756897609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03928-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03928-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The first affiliation has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Jiangxi Medical College, Nanchang University(NO.JXMCST).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients obtained written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}